NSC |
Compound |
Enrichment |
Correlation |
NSC 339137 |
PHYSALOLACTONE |
0.0378615809326463 |
0.38701589 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0378615809326463 |
0.31875654 |
NSC 354974 |
Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- |
0.0378615809326463 |
0.22157502 |
NSC 371777 |
Null |
0.0378615809326463 |
0.24045454 |
NSC 372155 |
2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- |
0.0378615809326463 |
0.57092155 |
NSC 40618 |
Cyclohexanone, 2,6-dibenzylidene- (8CI) |
0.0378615809326463 |
0.39126487 |
NSC 606499 |
Camptothecin Derivative |
0.0378615809326463 |
0.19625019 |
NSC 633963 |
N,N'-Di{1-methyl-2-[1-methyl-2-carboxamido(3-propionamidine) -4-pyrrole]-4-pyrrolyl}suberamide dihydrochloride |
0.0378615809326463 |
0.083377822 |
NSC 637411 |
Null |
0.0378615809326463 |
0.13550204 |
NSC 641454 |
3'-O-(Dimethylaminoethylcarbonyl)-(Z)-combretastatin A-4 |
0.0378615809326463 |
0.045315608 |